CorMedix, Inc.
(NYSE Amex Equities : CRMD)

( )
CRMD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific Inc.
0.21%284.231.0%$453.34m
MDTMedtronic PLC
-0.02%107.560.6%$434.49m
ABTAbbott Laboratories
0.23%79.810.8%$318.41m
BSXBoston Scientific Corporation
-0.71%37.961.1%$289.96m
ISRGIntuitive Surgical, Inc.
0.16%518.882.4%$288.76m
EWEdwards Lifesciences Corporation
-0.24%226.561.2%$255.27m
SYKStryker Corporation
-0.57%212.601.3%$237.39m
BDXBecton, Dickinson and Company
-0.91%250.551.1%$233.41m
ALGNAlign Technology, Inc.
2.49%205.156.3%$232.09m
BAXBaxter International Inc.
-1.00%87.151.7%$226.28m
PODDInsulet Corporation
-0.74%152.256.9%$160.20m
ZBHZimmer Biomet Holdings, Inc.
-0.87%135.251.7%$139.05m
WATWaters Corporation
0.12%213.884.0%$124.72m
ABMDABIOMED, Inc.
4.05%176.513.3%$113.51m
PENPenumbra, Inc.
-0.78%144.808.7%$107.81m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company, which seeks to in-license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The firm is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.